Article
Trump's Blockade Is Breaking Iran... And European Elites Are Angry
Trump's Blockade Is Breaking Iran... And European Elites Are Angry
Authored by Brandon Smith via Alt-Market.us
In March I published an article titled “Global Energy Crisis Or Iranian Surrender In Five Weeks?” in which I outlined the “worst case” and “best case” scenarios for the war in Iran. In my best case scenario I argued in favor of a specific plan to end the conflict quickly: A US naval blockade of the Strait of Hormuz, flipping the tables on Iran by blocking or seizing any oil tankers or gas tankers which...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Apr 14, 2026 / Tyler Durden
Fed Chair Nominee Kevin Warsh Reveals Assets Worth Over $190 Million
Fed Chair Nominee Kevin Warsh Reveals Assets Worth Over $190 Million
Trump's nominee for next Fed Chair, Kevin Warsh, disclosed assets with his wife, heiress Jane Lauder, that total at least $192 million, though - according to Bloomberg - "the actual figure for their holdings is certainly much higher", underscoring the extent of his close ties to Wall Street through personal investments and advisory positions. Warsh, who was chosen in January by President Donald Trump to succeed Jay Powell, received more than $13 million in consulting fees last year, including $10.2...
Read more
Sep 25, 2026 / Tyler Durden
Jefferies, Goldman, Now Stifel: Wall Street Races To Cover Almonty As "Owning The Bottlenecks" Theme Gains Momentum
Jefferies, Goldman, Now Stifel: Wall Street Races To Cover Almonty As "Owning The Bottlenecks" Theme Gains Momentum
A sense of urgency is building across Wall Street as notable desks push clients toward the critical materials theme we already laid out for readers, as the Trump administration accelerates efforts to rebuild conflict-free supply chains and reduce dependence on China. Resource nationalism and the looming rearmament supercycle are turning secure access to critical materials into both a national security priority and a multiyear investment theme.
For miners already producing conflict-free critical materials outside...
Read more
May 21, 2026 / Tyler Durden
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results
Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery.
In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks:
12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight.
9 mg dose: average weight loss of 64.4 pounds, or 25.9%.
4 mg dose: average weight loss of 47.2 pounds, or 19%
Ahead of the results,...
Read more




